ProShares Ultra Nasdaq Biotechnology
BIB
NASDAQ
| Weiss Ratings | BIB - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Weak | |||
| Reward Grade | D+ | |||
| Risk Index | Weak | |||
| Risk Grade | D+ | |||
| Valuation | BIB - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Price | $112.66 | |||
| Company Info | BIB - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Provider | ProShares | |||
| Manager/Tenure (Years) | Michael Neches (13), Tarak Davé (8) | |||
| Website | http://www.proshares.com | |||
| Phone Number | 866-776-5125 | |||
| Fund Information | BIB - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Fund Name | ProShares Ultra Nasdaq Biotechnology | |||
| Category | Trading--Leveraged Equity | |||
| Sub-Category | Trading Tools | |||
| Prospectus Objective | Specialty - Technology | |||
| Inception Date | Apr 06, 2010 | |||
| Open/Closed To New Investors | Open | |||
| Minimum Initial Investment | -- | |||
| Minimum Subsequent Investment | -- | |||
| Front End Fee | -- | |||
| Back End Fee | -- | |||
| Dividends and Shares | BIB - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield | 0.19% | |||
| Dividend | BIB - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield (Forward) | 0.59% | |||
| Asset Allocation | BIB - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash | 20.12% | |||
| Stock | 73.48% | |||
| U.S. Stock | 69.85% | |||
| Non-U.S. Stock | 3.63% | |||
| Bond | 0.00% | |||
| U.S. Bond | 0.00% | |||
| Non-U.S. Bond | 0.00% | |||
| Preferred | 0.00% | |||
| Convertible | 0.00% | |||
| Other Net | 6.40% | |||
| Price History | BIB - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -2.24% | |||
| 30-Day Total Return | 2.66% | |||
| 60-Day Total Return | -6.02% | |||
| 90-Day Total Return | 10.70% | |||
| Year to Date Total Return | 41.38% | |||
| 1-Year Total Return | 65.39% | |||
| 2-Year Total Return | 85.80% | |||
| 3-Year Total Return | 153.09% | |||
| 5-Year Total Return | 21.89% | |||
| Price | BIB - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Closing Price | $118.78 | |||
| 1-Month Low Price | $103.59 | |||
| 1-Month High Price | $120.53 | |||
| 52-Week Low Price | $68.29 | |||
| 52-Week Low Price (Date) | Nov 04, 2025 | |||
| 52-Week High Price | $126.22 | |||
| 52-Week High Price (Date) | Aug 19, 2026 | |||
| NAV | BIB - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 1-Month Low NAV | $103.67 | |||
| 1-Month High NAV | $120.64 | |||
| 52-Week Low NAV | $68.29 | |||
| 52-Week Low NAV (Date) | Nov 04, 2025 | |||
| 52-Week High NAV | $126.21 | |||
| 52-Week High Price (Date) | Aug 19, 2026 | |||
| Beta / Standard Deviation | BIB - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.49 | |||
| Standard Deviation | 33.99 | |||
| Balance Sheet | BIB - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Total Assets | 103.73M | |||
| Operating Ratios | BIB - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Expense Ratio | 0.95% | |||
| Turnover Ratio | 29.00% | |||
| Performance | BIB - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Last Bull Market Total Return | 87.30% | |||
| Last Bear Market Total Return | -21.66% | |||